Cucurbit[7]uril encapsulated cisplatin overcomes cisplatin resistance via a pharmacokinetic effect

Metallomics

Volumn 4, Issue 6, 2012, Pages 561-567

  Plumb, Jane A ^a   Venugopal, Balaji ^a   Oun, Rabbab ^a,b   Gomez Roman, Natividad ^a   Kawazoe, Yoshiyuki ^c   Venkataramanan, Natarajan Sathiyamoorthy ^c   Wheate, Nial J ^d  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b UNIVERSITY OF STRATHCLYDE   (United Kingdom)

^c TOHOKU UNIVERSITY   (Japan)

^d UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED SYSTEMS; ANTICANCER DRUG; CIS-PLATIN; CUCURBIT[7]URIL; CUCURBIT[N]URIL; DRUG DESIGN; DRUG RELEASE; DRUG RESISTANCE; DRUG SOLUBILITY; EQUIVALENT DOSE; HOST GUEST COMPLEXES; IN-VITRO; IN-VITRO ASSAYS; IN-VIVO; MACROCYCLES; OVARIAN CARCINOMA CELL; PLASMA LEVELS; PLATINUM ATOMS; SIDE EFFECT; SMALL MOLECULES; TISSUE DISTRIBUTIONS; TUMOUR GROWTH;

CELL CULTURE; DESIGN; DIAGNOSIS; DRUG DELIVERY; DRUG DOSAGE; HYDROGEN BONDS; PHARMACOKINETICS; PLATINUM; TUMORS;

PLATINUM COMPOUNDS;

CISPLATIN; CUCURBIT[7]URIL; MACROCYCLIC COMPOUND; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; BRIDGED COMPOUND; CUCURBIT(7)URIL; DRUG CARRIER; IMIDAZOLE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; CYTOTOXICITY; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG EFFECT; DRUG EXPOSURE; ENCAPSULATION; HUMAN; HUMAN CELL; HYDROGEN BOND; IN VITRO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR GROWTH; ANIMAL; CHEMICAL STRUCTURE; CHEMISTRY; DRUG RESISTANCE; DRUG SCREENING; EXPERIMENTAL NEOPLASM; METABOLISM; NUDE MOUSE; PATHOLOGY; TUMOR CELL LINE;

ANIMALS; ANTINEOPLASTIC AGENTS; BRIDGED COMPOUNDS; CELL LINE, TUMOR; CISPLATIN; DRUG CARRIERS; DRUG RESISTANCE, NEOPLASM; HUMANS; IMIDAZOLES; MICE; MICE, NUDE; MODELS, MOLECULAR; NEOPLASMS, EXPERIMENTAL; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84866447950     PISSN: 17565901     EISSN: 1756591X     Source Type: Journal    
DOI: 10.1039/c2mt20054f     Document Type: Article

References (42)

1. N. J. Wheate, S. Walker, G. E. Craig and R. Oun, Dalton Trans., 2010, 39, 8113-8127.
2. L. Kelland, Nat. Rev. Cancer, 2007, 7, 573-584.
3. N. J. Wheate and J. G. Collins, Coord. Chem. Rev., 2003, 241, 133-145.
4. N. J. Wheate and J. G. Collins, Curr. Med. Chem.: Anti-Cancer Agents, 2005, 5, 267-279.
5. F. Kratz, I. A. Muller, C. Ryppa and A. Warnecke, ChemMedChem, 2008, 3, 20-53.
6. J. Lagona, P. Mukhopadhyay, S. Chakrabarti and L. Isaacs, Angew. Chem.. Int. Ed., 2005, 44, 4844-4870.
7. J. Kim, I.-S. Jung, S.-Y. Kim, E. Lee, J.-K. Kang, S. Sakamoto, K. Yamaguchi and K. Kim, J. Am. Chem. Soc, 2000, 122, 540-541.
8. K. Kim, N. Selvapalam, Y. H. Ko, K. M. Park, D. Kim and J. Kim, Chem. Soc. Rev., 2007, 36, 267-279.
9. S. Walker, R. Oun, F. J. McInnes and N. J. Wheate, Isr. J. Chem., 2011, 51, 616-624.
10. N. J. Wheate, J. Inorg. Biochem., 2008, 102, 2060-2066.
11. N. i. Saleh, A. L. Koner and W. M. Nau, Angew. Chem., Int. Ed., 2008, 47, 5398-5401.
12. S. Kemp, N. J. Wheate, M. P. Pisani and J. R. Aldrich-Wright, J. Med. Chem., 2008, 51, 2787-2794.
13. R. Wang and D. H. Macartney, Org. Biomol. Chem., 2008, 6, 1955-1960.
14. F. J. McInnes, N. G. Anthony, A. R. Kennedy and N. J. Wheate, Org. Biomol. Chem., 2010, 8, 765-773.
15. A. R. Kennedy, A. F. Florence, F. J. McInnes and N. J. Wheate, Dalton Trans., 2009, 7695-7700.
16. Y. Zhao, M. H. Pourgholami, D. L. Morris, J. G. Collins and A. I. Day, Org. Biomol. Chem., 2010, 8, 3328-3337.
17. Y. Zhao, D. P. Buck, D. L. Morris, M. H. Pourgholami, A. I. Day and J. G. Collins, Org. Biomol. Chem., 2008, 6, 4509-4515.
18. M. J. Pisani, Y. Zhao, L. Wallace, C. E. Woodward, F. R. Keene, A. I. Day and J. G. Collins, Dalton Trans., 2010, 2078-2086.
19. K. M. Park, K. Suh, H. Jung, D.-W. Lee, Y. Ahn, J. Kim, K. Baek and K. Kim, Chem. Commun., 2009, 71-73.
20. V. D. Uzunova, C. Cullinane, K. Brix, W. M. Nau and A. I. Day, Org. Biomol. Chem., 2010, 8, 2037-2042.
21. S. Walker, R. Kaur, F. J. McInnes and N. J. Wheate, Mol. Pharm., 2010, 7, 2166-2172.
22. N. J. Wheate, D. P. Buck, A. I. Day and J. G. Collins, Dalton Trans., 2006, 451-458.
23. M. S. Bali, D. P. Buck, A. J. Coe, A. I. Day and J. G. Collins, Dalton Trans., 2006, 5337-5344.
24. Y. J. Jeon, S.-Y. Kim, Y. H. Ko, S. Sakamoto, K. Yamaguchi and K. Kim, Org. Biomol. Chem., 2005, 3, 2122-2125.
25. D. A. Anthoney, A. J. McIlwrath, W. M. Gallagher, A. R. M. Edlin and R. Brown, Cancer Res., 1996, 56, 1374-1381.
26. D. R. Duckett, S. M. Bronstein, Y. Taya and P. Modrich, Proc. Natl. Acad. Sci. U. S. A., 1999, 96, 12384-12388.
27. J. Gong, A. Costanzo, H.-Q. Yang, G. Melino, W. G. Kaelin, M. Levrero and J. Y. J. Wang, Nature, 1999, 399, 806-809.
28. S. Aebi, D. Fink, R. Gordon, H. K. Kim, H. Zheng, J. L. Fink and S. B. Howell, Clin. Cancer Res., 1997, 3, 1763-1767.
29. R. Brown, G. L. Hirst, W. M. Gallagher, A. J. McIlwrath, G. P. Margison, A. G. J. van der Zee and D. A. Anthoney, Oncogene, 1997, 15, 45-52.
30. N. J. Toft, D. J. Winton, J. Kelly, L. A. Howard, M. Dekker, H. T. Riele, M. J. Arends, A. H. Wyllie, G. P. Margison and A. R. Clarke, Proc. Natl. Acad. Sci. U. S. A., 1999, 96, 3911-3914.
31. H. J. Mackay, D. Cameron, M. Rahilly, M. J. MacKean, J. Paul, S. B. Kaye and R. Brown, J. Clin. Oncol., 2000, 18, 87-93.
32. J. A. Plumb, G. Strathdee, J. Sludden, S. B. Kaye and R. Brown, Clin. Cancer Res., 2000, 60, 6039-6044.
33. N. J. Wheate, A. I. Day, R. J. Blanch, A. P. Arnold, C. Cullinane and J. G. Collins, Chem. Commun., 2004, 1424-1425.
34. S. Kemp, N. J. Wheate, S. Wang, J. G. Collins, S. F. Ralph, A. I. Day, V. J. Higgins and J. R. Aldrich-Wright, J. Biol. Inorg. Chem., 2007, 12, 969-979.
35. N. J. Wheate, R. I. Taleb, A. M. Krause-Heuer, R. L. Cook, S. Wang, V. J. Higgins and J. R. Aldrich-Wright, Dalton Trans., 2007, 5055-5064.
36. G. J. Kirkpatrick, J. A. Plumb, O. B. Sutcliffe, D. J. Flint and N. J. Wheate, J. Inorg. Biochem., 2011, 105, 1115-1122.
37. J. A. Plumb, G. Strathdee, J. Sludden, S. B. Kaye and R. Brown, Cancer Res., 2000, 60, 6039-6044.
38. A. M. Krause-Heuer, N. J. Wheate, M. J. Tilby, D. Pearson, C. J. Ottley and J. R. Aldrich-Wright, Inorg. Chem., 2008, 47, 6880-6888.
39. N. J. Wheate, G. M. Abbott, R. J. Tate, C. J. Clements, R. Edrada-Ebel and B. F. Johnston, J. Inorg. Biochem., 2009, 103, 448-454.
40. A. Day, A. P. Arnold, R. J. Blanch and B. Snushall, J. Org. Chem., 2001, 66, 8094-8100.
41. G. Strathdee, M. J. MacKeen, M. Illand and R. Brown, Oncogene, 1999, 18, 2335-2341.
42. J. A. Plumb, R. Milroy and S. B. Kaye, Cancer Res., 1989, 49, 4435-4440.